Abstract
Protein-Losing Enteropathy post Fontan palliation is associated with significant morbidity and mortality. To date, very little research has been carried out to improve early identification of enteric protein loss in these patients. We hypothesise that subclinical enteric protein loss may occur in patients post Fontan surgery. A cross-sectional study was performed on 43 patients post Fontan surgery. We collected specimens of stool and blood from patients with no symptoms of protein-losing enteropathy post Fontan. Stool samples were assessed for alpha one antitrypsin. The stool samples of two patients were discarded, leaving 41 stool samples. Blood samples were also collected to review albumin, C-reactive protein, liver and renal function. Twenty-eight (65%) of those enrolled were male. The median (IQR) age between Fontan and collection of study specimens was 3.5 (2–7) years. Two (5%) patients had elevated levels of alpha-1-antitrypsin. There was no correlation between blood biochemistry and elevated stool alpha-1-antitrypsin. Subclinical protein loss is rare in asymptomatic children after Fontan procedure with only 5% of patients having elevated stool alpha-1-antitrypsin but no other symptoms. These findings may relate to our small cohort size and the time to testing post cardiac surgery. Future longitudinal follow-up studies should assess the ability of alpha-1-antitrypsin to provide earlier detection of protein-losing enteropathy in asymptomatic patients post Fontan. Given the serious prognosis of protein-losing enteropathy in this patient group, further work is warranted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lenz D et al (2003) Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? Crit Care 7(2):185–190
Mertens L et al (1998) Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 115(5):1063–1073
Feldt RH et al (1996) Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 112(3):672–680
Meadows J, Jenkins K (2011) Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment. Cardiol Young 21(4):363–377
Rychik J, Spray TL (2002) Strategies to treat protein-losing enteropathy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:3–11
Gewillig M et al (2010) The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg 10(3):428–433
Rychik J, Piccoli DA, Barber G (1991) Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol 68(8):819–821
Ostrow AM, Freeze H, Rychik J (2006) Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 82(2):695–700
John AS et al (2014) Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 64(1):54–62
Chin AJ et al (2009) Serum alkaline phosphatase reflects post-Fontan hemodynamics in children. Pediatr Cardiol 30(2):138–145
Florent C et al (1981) Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology 81(4):777–780
Davis CA et al (1994) Enteric protein loss after the Fontan operation. Mayo Clin Proc 69(2):112–114
Fujii T et al (2003) Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations. J Pediatr Gastroenterol Nutr 37(5):577–580
Thorne SA et al (1998) Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease. Eur Heart J 19(3):514–520
Magazzu G et al (1985) Reliability and usefulness of random fecal alpha 1-antitrypsin concentration: further simplification of the method. J Pediatr Gastroenterol Nutr 4(3):402–407
Patel JK et al (2016) Early impact of fontan operation on enteric protein loss. Ann Thorac Surg 101(3):1025–1030
Rothman A, Snyder J (1991) Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy. Am Heart J 121(2 Pt 1):618–619
Thacker D et al (2010) Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 89(3):837–842
Reinhardt Z et al (2010) Sildenafil in the management of the failing Fontan circulation. Cardiol Young 20(5):522–525
Acknowledgements
We are grateful to our cardiology colleagues for allowing us to include their patients in this institutional study.
Financial Support
This research received no specific Grant from any funding agency, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All authors declared that they have competing interest.
Ethical Approval
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation and the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committees at Our Lady’s Hospital for Sick Children.
Rights and permissions
About this article
Cite this article
Breatnach, C.R., Cleary, A., Prendiville, T. et al. Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection. Pediatr Cardiol 39, 33–37 (2018). https://doi.org/10.1007/s00246-017-1720-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-017-1720-8